Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1954 1
1955 1
1956 2
1957 3
1958 3
1959 5
1960 5
1961 5
1962 6
1963 9
1964 12
1965 5
1966 7
1967 7
1968 8
1969 9
1970 13
1971 10
1972 8
1973 2
1974 11
1975 12
1976 11
1977 19
1978 22
1979 22
1980 31
1981 32
1982 30
1983 25
1984 43
1985 57
1986 62
1987 66
1988 64
1989 62
1990 60
1991 65
1992 75
1993 103
1994 78
1995 88
1996 114
1997 116
1998 101
1999 94
2000 109
2001 117
2002 135
2003 117
2004 142
2005 163
2006 201
2007 198
2008 202
2009 177
2010 218
2011 225
2012 235
2013 230
2014 289
2015 277
2016 299
2017 340
2018 333
2019 349
2020 391
2021 339
2022 325
2023 291
2024 193

Text availability

Article attribute

Article type

Publication date

Search Results

6,768 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines).
Hasegawa K, Takemura N, Yamashita T, Watadani T, Kaibori M, Kubo S, Shimada M, Nagano H, Hatano E, Aikata H, Iijima H, Ueshima K, Ohkawa K, Genda T, Tsuchiya K, Torimura T, Ikeda M, Furuse J, Akahane M, Kobayashi S, Sakurai H, Takeda A, Murakami T, Motosugi U, Matsuyama Y, Kudo M, Tateishi R; committee for Revision of the Clinical Practice Guidelines for Hepatocellular Carcinoma, Tokyo, Japan. Hasegawa K, et al. Among authors: yamashita t. Hepatol Res. 2023 May;53(5):383-390. doi: 10.1111/hepr.13892. Epub 2023 Mar 10. Hepatol Res. 2023. PMID: 36826411
Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01).
Saura C, Modi S, Krop I, Park YH, Kim SB, Tamura K, Iwata H, Tsurutani J, Sohn J, Mathias E, Liu Y, Cathcart J, Singh J, Yamashita T. Saura C, et al. Among authors: yamashita t. Ann Oncol. 2024 Mar;35(3):302-307. doi: 10.1016/j.annonc.2023.12.001. Epub 2023 Dec 11. Ann Oncol. 2024. PMID: 38092229 Free PMC article. Clinical Trial.
Maternal cardiopulmonary resuscitation.
Tanaka H, Matsunaga S, Furuta M, Kato R, Takahashi S, Takeda J, Nakao M, Nakamura E, Nii M, Yamashita T, Yamahata Y, Enomoto N, Tsuji M, Baba S, Hosokawa Y, Maenaka T, Sakurai A. Tanaka H, et al. Among authors: yamashita t. J Obstet Gynaecol Res. 2023 Jan;49(1):54-67. doi: 10.1111/jog.15466. Epub 2022 Oct 18. J Obstet Gynaecol Res. 2023. PMID: 36257320 Review.
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persisters.
Li M, Nishimura T, Takeuchi Y, Hongu T, Wang Y, Shiokawa D, Wang K, Hirose H, Sasahara A, Yano M, Ishikawa S, Inokuchi M, Ota T, Tanabe M, Tada KI, Akiyama T, Cheng X, Liu CC, Yamashita T, Sugano S, Uchida Y, Chiba T, Asahara H, Nakagawa M, Sato S, Miyagi Y, Shimamura T, Nagai LAE, Kanai A, Katoh M, Nomura S, Nakato R, Suzuki Y, Tojo A, Voon DC, Ogawa S, Okamoto K, Foukakis T, Gotoh N. Li M, et al. Among authors: yamashita t. J Clin Invest. 2023 Nov 15;133(22):e166666. doi: 10.1172/JCI166666. J Clin Invest. 2023. PMID: 37966117 Free PMC article.
DOCK2 is involved in the host genetics and biology of severe COVID-19.
Namkoong H, Edahiro R, Takano T, Nishihara H, Shirai Y, Sonehara K, Tanaka H, Azekawa S, Mikami Y, Lee H, Hasegawa T, Okudela K, Okuzaki D, Motooka D, Kanai M, Naito T, Yamamoto K, Wang QS, Saiki R, Ishihara R, Matsubara Y, Hamamoto J, Hayashi H, Yoshimura Y, Tachikawa N, Yanagita E, Hyugaji T, Shimizu E, Katayama K, Kato Y, Morita T, Takahashi K, Harada N, Naito T, Hiki M, Matsushita Y, Takagi H, Aoki R, Nakamura A, Harada S, Sasano H, Kabata H, Masaki K, Kamata H, Ikemura S, Chubachi S, Okamori S, Terai H, Morita A, Asakura T, Sasaki J, Morisaki H, Uwamino Y, Nanki K, Uchida S, Uno S, Nishimura T, Ishiguro T, Isono T, Shibata S, Matsui Y, Hosoda C, Takano K, Nishida T, Kobayashi Y, Takaku Y, Takayanagi N, Ueda S, Tada A, Miyawaki M, Yamamoto M, Yoshida E, Hayashi R, Nagasaka T, Arai S, Kaneko Y, Sasaki K, Tagaya E, Kawana M, Arimura K, Takahashi K, Anzai T, Ito S, Endo A, Uchimura Y, Miyazaki Y, Honda T, Tateishi T, Tohda S, Ichimura N, Sonobe K, Sassa CT, Nakajima J, Nakano Y, Nakajima Y, Anan R, Arai R, Kurihara Y, Harada Y, Nishio K, Ueda T, Azuma M, Saito R, Sado T, Miyazaki Y, Sato R, Haruta Y, Nagasaki T, Yasui Y, Hasegawa Y, Mutoh Y, Kimura T, Sato T, Takei R, Hagimoto S,… See abstract for full author list ➔ Namkoong H, et al. Among authors: yamashita t. Nature. 2022 Sep;609(7928):754-760. doi: 10.1038/s41586-022-05163-5. Epub 2022 Aug 8. Nature. 2022. PMID: 35940203 Free PMC article.
Origin of Transthyretin in Cerebral Amyloid Angiopathy.
Nomura T, Misumi Y, Tasaki M, Obayashi K, Yamashita T, Ando Y, Ueda M. Nomura T, et al. Among authors: yamashita t. JAMA Neurol. 2024 Feb 26;81(4):421-3. doi: 10.1001/jamaneurol.2023.5762. Online ahead of print. JAMA Neurol. 2024. PMID: 38407867
Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs.
Wang W, Bale S, Wei J, Yalavarthi B, Bhattacharyya D, Yan JJ, Abdala-Valencia H, Xu D, Sun H, Marangoni RG, Herzog E, Berdnikovs S, Miller SD, Sawalha AH, Tsou PS, Awaji K, Yamashita T, Sato S, Asano Y, Tiruppathi C, Yeldandi A, Schock BC, Bhattacharyya S, Varga J. Wang W, et al. Among authors: yamashita t. Nat Commun. 2022 Oct 26;13(1):6358. doi: 10.1038/s41467-022-33767-y. Nat Commun. 2022. PMID: 36289219 Free PMC article.
6,768 results